Human immunology · 2026
Challenges in HLA and ABO typing of deceased organ donors with prior hematopoietic stem cell transplantation: two cases and practical considerations for evaluation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xu Qingyong, Stone Kristen, Helmick Dennis, Baumgartner Nina, Ruggio Natalie, Chen Dongfeng, Gunaratnam Lakshman, Ho Sam
Аннотация
BACKGROUND: Prior allogeneic hematopoietic stem cell transplantation (HSCT) can complicate HLA and ABO typing of deceased organ donors because circulating hematopoietic cells and organs may originate from different sources.
CASE PRESENTATIONS: We describe two deceased organ donors with prior HSCT. In Case 1, historical records demonstrated discordance at HLA-C and HLA-DQ between the HSCT donor and the constitutional pre-HSCT typing. Peripheral-blood HLA typing reflected the HSCT donor, while a kidney blood-vessel specimen yielded four DPB1 alleles from mixed sources, permitting only a presumptive kidney DPB1 assignment. In Case 2, HLA assignments were concordant after childhood HSCT, but ABO serology was O/A ambiguous, resulting in allocation as blood group AB. Retrospective molecular ABO genotyping and chimerism testing demonstrated mixed donor- and recipient-derived DNA in buccal specimens.
CONCLUSIONS: HSCT-associated chimerism can complicate deceased-donor HLA and ABO typing. Interpretation should integrate transplant history, historical records, specimen source, serology, and molecular testing when indicated.
CASE PRESENTATIONS: We describe two deceased organ donors with prior HSCT. In Case 1, historical records demonstrated discordance at HLA-C and HLA-DQ between the HSCT donor and the constitutional pre-HSCT typing. Peripheral-blood HLA typing reflected the HSCT donor, while a kidney blood-vessel specimen yielded four DPB1 alleles from mixed sources, permitting only a presumptive kidney DPB1 assignment. In Case 2, HLA assignments were concordant after childhood HSCT, but ABO serology was O/A ambiguous, resulting in allocation as blood group AB. Retrospective molecular ABO genotyping and chimerism testing demonstrated mixed donor- and recipient-derived DNA in buccal specimens.
CONCLUSIONS: HSCT-associated chimerism can complicate deceased-donor HLA and ABO typing. Interpretation should integrate transplant history, historical records, specimen source, serology, and molecular testing when indicated.